Tahira Bokhari, MD
NPI 1619075009 · Allergy & Immunology Physician · Fairlawn, NJ
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1619075009
- Entity type
- Individual
- Primary specialty
- Allergy & Immunology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- MA40419 (NJ)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
128 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Professional Service for Multiple Injections of Allergen95117 | 75 | $14 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 29 | $100 |
| Test to Measure Expiratory Airflow and Volume94010 | 24 | $31 |
Typical Medicare-allowed amounts for these services range $14–$100 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Montelukast Sodium | 84 | 31 |
| Levocetirizine Dihydrochloride | 63 | 27 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 43 | 12 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 37 | 21 |
| Fluticasone Propionate | 30 | 20 |
| Triamcinolone Acetonide | 24 | 13 |
| Famotidine | 23 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$749 across 47 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-09-20
- Last updated
- 2016-07-22
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.